EVEREST

EverNov Medicines Limited

Application Filed: 2019-08-19
Trademark Application Details
Trademark Logo EVEREST

Mark For: EVEREST™ trademark registration is intended to cover the categories of active chemical ingredients for use in the manufacture of anti-cancer drugs; chemical additives for use in the manufacture of medicines; chemical substances for use in the production of drugs. [all]

Status

2021-07-25 UTC
DEAD UNKNOWN


Research OneLook Acronym Finder
Serial Number88584518
Mark Literal ElementsEVEREST
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK. SERVICE MARK
RegisterPRINCIPAL
Current LocationGENERIC WEB UPDATE 2020-11-30
Basis1(b)
Class StatusABANDONED
Primary US Classes
  • 001: Raw or Partly Prepared Materials
  • 005: Adhesives
  • 006: Chemicals and Chemical Compositions
  • 010: Fertilizers
  • 026: Measuring and Scientific Appliances
  • 046: Foods and Ingredients of Foods
Primary International Class
  • 001 - Primary Class
  • (Chemicals) Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
Filed UseYes
Current UseNo
Intent To UseYes
Filed ITUNo
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameDavid Devernoe
Attorney Docket Number5557.27003
Law Office AssignedL50
Employee NameFIORELLI, JOANNA ELISA

Timeline

2017-10-27Date of First Use
2019-08-19Application Filed
2019-11-20Location: TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED
2019-11-20Status: Live/Pending
2019-11-25Transaction Date
2020-09-22Published
2020-11-30Location: GENERIC WEB UPDATE
2020-11-30Status: Abandoned after publication because applicant filed an express abandonment. To view all documents in this file, click on the Tra

Trademark Parties (Applicants & Owners)

Party: EverNov Medicines Limited
Address66th Floor, Tower 1, Plaza 66 West Nanjing 1266 Shanghai CHINA 200040
Legal Entity TypeLimited Liability Company
Legal Entity StateCHINA

Documents

DrawingJPEG2019-08-19
SpecimenJPEG2019-08-19
TEAS RF New ApplicationMULTI2019-08-19
Administrative ResponseXML2019-10-16
XSearch Search SummaryXML2019-11-18
Offc Action OutgoingMULTI2019-11-20
Response to Office ActionMULTI2020-04-15
SpecimenJPEG2020-04-15
Amendment and Mail Process CompleteMULTI2020-04-17
Offc Action OutgoingXML2020-06-04
Response to Office ActionMULTI2020-06-24
Amendment and Mail Process CompleteMULTI2020-07-14
Offc Action OutgoingXML2020-08-03
Response to Office ActionXML2020-08-17
Amendment and Mail Process CompleteAPPLICATION/XML,IMAGE/JPEG2020-08-18
TRAM Snapshot of App at Pub for OppostnAPPLICATION/XML,IMAGE/JPEG2020-08-19
Notice of PublicationXML2020-09-02
Notification Of Notice of PublicationXML2020-09-02
OG Publication ConfirmationAPPLICATION/XML2020-09-22
Express AbandonmentXML2020-11-24
Notice of AbandonmentAPPLICATION/XML2020-11-30

Attorney of Record

DAVID DEVERNOE
RIMON, P.C.
440 STEVENS AVE., SUITE 200
SOLANA BEACH, CA 92075

Good, Services, and Codes


IC 001. US 001 005 006 010 026 046. G & S: Active chemical ingredients for use in the manufacture of anti-cancer drugs; chemical additives for use in the manufacture of medicines; chemical substances for use in the production of drugs. FIRST USE: 20171027. FIRST USE IN COMMERCE: 20171027
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceuticals; pharmaceutical research; pharmaceutical drugs; pharmaceutical preparations; pharmaceutical services; research and development of pharmaceuticals; pharmaceutical preparations for health care; medicated and pharmaceutical preparations for use in connection with humans. FIRST USE: 20171027. FIRST USE IN COMMERCE: 20171027
IC 042. US 100 101. G & S: Drug Development; drug discovery; pharmaceutical drug development services; research and development of vaccines and medicines. FIRST USE: 20171027. FIRST USE IN COMMERCE: 20171027

International Codes:1
U.S. Codes:001,005,006,010,026,046
International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:42
U.S. Codes:100,101
Type CodeType
GS0011Active chemical ingredients for use in the manufacture of anti-cancer drugs; chemical additives for use in the manufacture of medicines; chemical substances for use in the production of drugs

Trademark Filing History

DescriptionDateProceeding Number
ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION2020-11-30
ABANDONMENT - AFTER PUBLICATION2020-11-30
TEAS EXPRESS ABANDONMENT RECEIVED2020-11-24
PUBLISHED FOR OPPOSITION2020-09-22
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2020-09-22
EXTENSION OF TIME TO OPPOSE RECEIVED2020-09-22
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2020-09-02
APPROVED FOR PUB - PRINCIPAL REGISTER2020-08-18
TEAS/EMAIL CORRESPONDENCE ENTERED2020-08-1788889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2020-08-17
CORRESPONDENCE RECEIVED IN LAW OFFICE2020-08-1788889
NOTIFICATION OF NON-FINAL ACTION E-MAILED2020-08-036325
NON-FINAL ACTION WRITTEN2020-08-0393657
NON-FINAL ACTION E-MAILED2020-08-036325
TEAS/EMAIL CORRESPONDENCE ENTERED2020-07-1366213
CORRESPONDENCE RECEIVED IN LAW OFFICE2020-07-1366213
ASSIGNED TO LIE2020-07-0666213
TEAS RESPONSE TO OFFICE ACTION RECEIVED2020-06-24
NOTIFICATION OF NON-FINAL ACTION E-MAILED2020-06-046325
NON-FINAL ACTION WRITTEN2020-06-0493657
NON-FINAL ACTION E-MAILED2020-06-046325
ASSIGNED TO EXAMINER2020-05-2093657
TEAS/EMAIL CORRESPONDENCE ENTERED2020-04-1688889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2020-04-15
CORRESPONDENCE RECEIVED IN LAW OFFICE2020-04-1588889
NOTIFICATION OF NON-FINAL ACTION E-MAILED2019-11-206325
NON-FINAL ACTION WRITTEN2019-11-2090289
NON-FINAL ACTION E-MAILED2019-11-206325
ASSIGNED TO EXAMINER2019-11-1890289
LETTER OF PROTEST EVIDENCE FORWARDED2019-10-16
LETTER OF PROTEST ACCEPTED2019-10-16
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-09-04
NEW APPLICATION ENTERED IN TRAM2019-08-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed